Welcome to the Annual Meeting 2024

Download the Congress App

Download the congress app on your smartphone so that you always have access to the program and are informed about the latest news! 
Just scan the QR code below or click on the following link: https://qr1.be/WZB4

Dear members, dear colleagues

We are delighted to invite you to the Annual Meeting 2024 of the Swiss Neurological Society (SNS) in Basel. This year we are very pleased to welcome the two guest societies Swiss League Against Epilepsy (SEL) and Swiss Society for Cognitive and Behavioural Neurology (SSCBN).

The motto of the meeting is: Quo vadis neuroinflammation? From pathophysiologic advances to novel treatment strategies. The meeting will feature invited experts from across Switzerland and abroad discussing ongoing diagnostic and therapeutic challenges and advances in neurology and providing insights on cutting edge neurological research with a focus on neuroimmunological diseases including diagnostic and therapeutic advances. Further, there will be ample opportunities for oral and poster presentations of invited abstracts including a platform for presentations by young neurologists in training.

The 4th Symposium Interprofessional Neurology: NeuroCare will again be an integral part of the program. Additionally, you can look forward to an interesting industry exhibition by our partners and sponsors, who will be presenting their latest products and exchanging ideas with you.

Who should attend?

  • Neurologists
  • Members of SNS, SEL and SSCBN
  • Neurology residents 
  • Neurological nursing staff & medical practice personnel 
  • Researchers in the field of neurology 
  • Medical students 
  • Experts from related disciplines (e.g. neuropsychology, neuroscience, etc.)

Top Reasons to attend

By taking part, you will have the opportunity to gain more in-depth knowledge about the following topics:

  • Big Data and artificial intelligence in neurology
  • Neuroupdate 1: Novel immune mechanisms in neurological diseases 
  • Neuroupdate 2: Novel immune therapies and neurological side effects of novel therapies 
  • Differential diagnosis auf demyelinating CNS disease (MOGAD, NMOSD, MS) 
  • Autoimmunity, seizures, encephalitis
  • CIDP, myasthenia, myositis 
  • Recent advances in clinical neuroimaging 
  • Evaluation of unresponsive patients after encephalitis and neurorehabilitation in the very acute and post-acute phase
  • Epilepsy
  • WIN – Women in Neurology
  • SAYN Forum & SAYN GemSession

We are looking forward to an exciting and enriching Annual Meeting 2024 and send you already now a warm welcome to the vibrant city of Basel.

Prof. Urs Fischer, MD
SNS President
Prof. Anne-Katrin Pröbstel, MD
Congress President